申请人:BELLENIE Benjamin Richard
公开号:US20170042889A1
公开(公告)日:2017-02-16
The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.